Cheng-Ping Wang
Overview
Explore the profile of Cheng-Ping Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
1269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Yu K, Chen T, Tsai M, Kang C, Chien C, et al.
Oral Oncol
. 2025 Feb;
162:107210.
PMID: 39947008
Background: To characterize multistate oral carcinogenesis, we conducted a cohort study of patients with oral precancer and a parallel case-control study of oral cancers and controls in Taiwan. Methods: During...
2.
Jackson S, Francis J, Pfeiffer R, Proietti C, Coghill A, Yu K, et al.
J Infect Dis
. 2025 Feb;
PMID: 39932888
We investigated anti-EBV IgA and IgG responses by sex among 387 cancer-free individuals in Asia. Antibody responses were measured using an EBV proteome array to assess age-adjusted sex-specific associations with...
3.
Liao Y, Chen Y, Hsieh M, Lin M, Wang C, Wang C, et al.
Head Neck
. 2024 Nov;
47(2):667-678.
PMID: 39497264
Background: Extranodal extension (ENE) had been included in the latest cancer staging system in hypopharyngeal squamous cell carcinoma (HypoSCC). However, the impact of ENE on HypoSCC survival and treatment outcomes...
4.
Klibngern H, Kang C, Lee L, Ng S, Lin C, Fan K, et al.
Oral Oncol
. 2024 Nov;
159:107102.
PMID: 39488902
Background: The prognostic significance of margin-to-depth ratio (MDR) in oral cavity squamous cell carcinoma (OCSCC) remains unclear, particularly in comparison to traditional margin status. We aimed to examine the association...
5.
Huang H, Huang Y, Chen Y, Wu H, Hsu C, Kao H, et al.
Oncogenesis
. 2024 Oct;
13(1):36.
PMID: 39353912
Immunotherapy has revolutionized cancer treatment, but the lack of a reliable predictive biomarker for treatment response remains a challenge. Alpha-1,6-Mannosylglycoprotein 6-β-N-Acetylglucosaminyltransferase 5 (MGAT5) is a key regulator of complex N-glycan...
6.
Liu K, Hsu W, Bu W, Yu K, Wang C, Chien Y, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae464.
PMID: 39229285
Elevated levels of Epstein-Barr virus (EBV) gp350 and gH/gL antibodies have been associated with a lower risk of developing nasopharyngeal carcinoma (NPC), although the evidence remains inconclusive and unexplained. We...
7.
Chang C, Lin P, Hung C, Wang C, Lou P, Ho S, et al.
Ann Surg Oncol
. 2024 Aug;
31(13):9117-9124.
PMID: 39154160
Background: Human papillomavirus (HPV) is a crucial prognostic factor in oropharyngeal cancer (OPC). p16 is a surrogate marker for diagnosing HPV+ OPC, however it is not direct evidence of HPV...
8.
Hsu W, Tao J, Fu S, Yu K, Simon J, Chen T, et al.
Int J Cancer
. 2024 Jun;
155(8):1400-1408.
PMID: 38822730
Nasopharyngeal carcinoma (NPC) risk prediction models based on Epstein-Barr virus (EBV)-antibody testing have shown potential for screening of NPC; however, the long-term stability is unclear. Here, we investigated the kinetics...
9.
Xue Z, Oguguo T, Yu K, Chen T, Hua C, Kang C, et al.
Proc SPIE Int Soc Opt Eng
. 2024 May;
12931.
PMID: 38774479
For deep learning-based machine learning, not only are large and sufficiently diverse data crucial but their good qualities are equally important. However, in real-world applications, it is very common that...
10.
Hung C, Lee T, Chang C, Wang C, Lin M, Lou P, et al.
Oral Oncol
. 2024 Feb;
151:106726.
PMID: 38377691
Objectives: In early-stage oral squamous cell carcinoma (OSCC) patients, whether the margin-to-depth-of-invasion ratio (MDR) can assist in stratifying the prognosis remains unclear. Methods: Patients diagnosed with early stage OSCC at...